<DOC>
	<DOC>NCT02112903</DOC>
	<brief_summary>The purpose of this study is to evaluate the gastro-intestinal tolerability (nausea, vomiting, diarrhoea, abdominal discomfort, and abdominal pain) of vortioxetine following single oral doses of three modified-release (MR) capsules with differently coated multiple particles compared to one immediate-release (IR) tablet.</brief_summary>
	<brief_title>Study Comparing the Gastro-intestinal Tolerability and Absorption Profile of Vortioxetine After Administration of Modified-release Formulations and Immediate-release Formulation in Healthy Women</brief_title>
	<detailed_description />
	<mesh_term>Vortioxetine</mesh_term>
	<criteria>Healthy women ≥18 and ≤45 years of age with a body mass index (BMI) of &gt;18.5 and &lt;30.0 kg/m2. Women will be of childbearing potential with a confirmed nonpregnant and nonlactating status. Other protocoldefined Inclusion and Exclusion Criteria may apply.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>